674 related articles for article (PubMed ID: 24877179)
1. Nebivolol potentiates the efficacy of PDE5 inhibitors to relax corpus cavernosum and penile arteries from diabetic patients by enhancing the NO/cGMP pathway.
Martínez-Salamanca JI; La Fuente JM; Cardoso J; Fernández A; Cuevas P; Wright HM; Angulo J
J Sex Med; 2014 May; 11(5):1182-92. PubMed ID: 24877179
[TBL] [Abstract][Full Text] [Related]
2. Ca2+ -activated K+ channel (KCa) stimulation improves relaxant capacity of PDE5 inhibitors in human penile arteries and recovers the reduced efficacy of PDE5 inhibition in diabetic erectile dysfunction.
González-Corrochano R; La Fuente J; Cuevas P; Fernández A; Chen M; Sáenz de Tejada I; Angulo J
Br J Pharmacol; 2013 May; 169(2):449-61. PubMed ID: 23441682
[TBL] [Abstract][Full Text] [Related]
3. Nebivolol dilates human penile arteries and reverses erectile dysfunction in diabetic rats through enhancement of nitric oxide signaling.
Angulo J; Wright HM; Cuevas P; González-Corrochano R; Fernández A; Cuevas B; La Fuente JM; Gupta S; Sáenz de Tejada I
J Sex Med; 2010 Aug; 7(8):2681-97. PubMed ID: 20214719
[TBL] [Abstract][Full Text] [Related]
4. Diabetes exacerbates the functional deficiency of NO/cGMP pathway associated with erectile dysfunction in human corpus cavernosum and penile arteries.
Angulo J; González-Corrochano R; Cuevas P; Fernández A; La Fuente JM; Rolo F; Allona A; Sáenz de Tejada I
J Sex Med; 2010 Feb; 7(2 Pt 1):758-68. PubMed ID: 19912487
[TBL] [Abstract][Full Text] [Related]
5. Synergistic effects of BAY 60-4552 and vardenafil on relaxation of corpus cavernosum tissue of patients with erectile dysfunction and clinical phosphodiesterase type 5 inhibitor failure.
Albersen M; Linsen L; Tinel H; Sandner P; Van Renterghem K
J Sex Med; 2013 May; 10(5):1268-77. PubMed ID: 23421435
[TBL] [Abstract][Full Text] [Related]
6. L-cysteine/hydrogen sulfide pathway induces cGMP-dependent relaxation of corpus cavernosum and penile arteries from patients with erectile dysfunction and improves arterial vasodilation induced by PDE5 inhibition.
La Fuente JM; Fernández A; Pepe-Cardoso AJ; Martínez-Salamanca JI; Louro N; Angulo J
Eur J Pharmacol; 2019 Nov; 863():172675. PubMed ID: 31542487
[TBL] [Abstract][Full Text] [Related]
7. Effect of the phosphodiesterase 5 inhibitors sildenafil, tadalafil and vardenafil on rat anococcygeus muscle: functional and biochemical aspects.
Toque HA; Priviero FB; Zemse SM; Antunes E; Teixeira CE; Webb RC
Clin Exp Pharmacol Physiol; 2009 Apr; 36(4):358-66. PubMed ID: 18986324
[TBL] [Abstract][Full Text] [Related]
8. Comparative relaxing effects of sildenafil, vardenafil, and tadalafil in human corpus cavernosum: contribution of endogenous nitric oxide release.
Toque HA; Priviero FB; Teixeira CE; Claudino MA; Baracat JS; Fregonesi A; De Nucci G; Antunes E
Urology; 2009 Jul; 74(1):216-21. PubMed ID: 19371941
[TBL] [Abstract][Full Text] [Related]
9. The phosphodiesterase inhibitory selectivity and the in vitro and in vivo potency of the new PDE5 inhibitor vardenafil.
Saenz de Tejada I; Angulo J; Cuevas P; Fernández A; Moncada I; Allona A; Lledó E; Körschen HG; Niewöhner U; Haning H; Pages E; Bischoff E
Int J Impot Res; 2001 Oct; 13(5):282-90. PubMed ID: 11890515
[TBL] [Abstract][Full Text] [Related]
10. Diabetes impairs endothelium-dependent relaxation of human penile vascular tissues mediated by NO and EDHF.
Angulo J; Cuevas P; Fernández A; Gabancho S; Allona A; Martín-Morales A; Moncada I; Videla S; Sáenz de Tejada I
Biochem Biophys Res Commun; 2003 Dec; 312(4):1202-8. PubMed ID: 14652001
[TBL] [Abstract][Full Text] [Related]
11. Overview of phosphodiesterase 5 inhibition in erectile dysfunction.
Rosen RC; Kostis JB
Am J Cardiol; 2003 Nov; 92(9A):9M-18M. PubMed ID: 14609619
[TBL] [Abstract][Full Text] [Related]
12. In vitro effects of PDE5 inhibitors sildenafil, vardenafil and tadalafil on isolated human ureteral smooth muscle: a basic research approach.
Gratzke C; Uckert S; Kedia G; Reich O; Schlenker B; Seitz M; Becker AJ; Stief CG
Urol Res; 2007 Feb; 35(1):49-54. PubMed ID: 17102958
[TBL] [Abstract][Full Text] [Related]
13. Vardenafil and resveratrol synergistically enhance the nitric oxide/cyclic guanosine monophosphate pathway in corpus cavernosal smooth muscle cells and its therapeutic potential for erectile dysfunction in the streptozotocin-induced diabetic rat: preliminary findings.
Fukuhara S; Tsujimura A; Okuda H; Yamamoto K; Takao T; Miyagawa Y; Nonomura N; Okuyama A
J Sex Med; 2011 Apr; 8(4):1061-71. PubMed ID: 21269399
[TBL] [Abstract][Full Text] [Related]
14. The role of PDE5 inhibitors in heme oxygenase-cGMP relationship in rat cavernous tissues.
Aziz MT; Mostafa T; Atta H; Rashed L; Marzouk SA; Obaia EM; Sabry D; Hassouna AA; El-Shehaby AM; Aziz AT
J Sex Med; 2008 Jul; 5(7):1636-45. PubMed ID: 18208506
[TBL] [Abstract][Full Text] [Related]
15. STIM/Orai Inhibition as a Strategy for Alleviating Diabetic Erectile Dysfunction Through Modulation of Rat and Human Penile Tissue Contractility and in vivo Potentiation of Erectile Responses.
Sevilleja-Ortiz A; El Assar M; García-Gómez B; La Fuente JM; Alonso-Isa M; Romero-Otero J; Martínez-Salamanca JI; Fernández A; Rodríguez-Mañas L; Angulo J
J Sex Med; 2022 Dec; 19(12):1733-1749. PubMed ID: 36195535
[TBL] [Abstract][Full Text] [Related]
16. Vardenafil improves penile erection in type 2 diabetes mellitus patients with erectile dysfunction: role of tropomyosin.
Zamorano-León JJ; Olivier C; de Las Heras N; Mateos-Cáceres PJ; Brime Menéndez R; Rodríguez-Sierra P; Martín Palacios N; Manso LS; Modrego J; Segura A; Macaya C; López-Farré AJ
J Sex Med; 2013 Dec; 10(12):3110-20. PubMed ID: 24112450
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of the phosphodiesterase type 5 inhibitors sildenafil, vardenafil, and tadalafil in rat aorta.
Teixeira CE; Priviero FB; Webb RC
J Pharmacol Exp Ther; 2006 Feb; 316(2):654-61. PubMed ID: 16204472
[TBL] [Abstract][Full Text] [Related]
18. Effects of the recreational use of PDE5 inhibitors on the corpus cavernosum of young, healthy rats.
Simsek A; Tugcu V; Erturkuner P; Alkan F; Ozbek E; Tasci AI
Int Urol Nephrol; 2014 Oct; 46(10):1889-93. PubMed ID: 24859322
[TBL] [Abstract][Full Text] [Related]
19. Phosphodiesterase type 5 as a pharmacologic target in erectile dysfunction.
Corbin JD; Francis SH; Webb DJ
Urology; 2002 Sep; 60(2 Suppl 2):4-11. PubMed ID: 12414329
[TBL] [Abstract][Full Text] [Related]
20. Nitrergic function is lost but endothelial function is preserved in the corpus cavernosum and penile resistance arteries of men after radical prostatectomy.
Martínez-Salamanca JI; La Fuente JM; Fernández A; Martínez-Salamanca E; Pepe-Cardoso AJ; Carballido J; Angulo J
J Sex Med; 2015 Mar; 12(3):590-9. PubMed ID: 25529966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
